A detailed history of Sigma Planning Corp transactions in Amgen Inc stock. As of the latest transaction made, Sigma Planning Corp holds 17,303 shares of AMGN stock, worth $5.38 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
17,303
Previous 6,434 168.93%
Holding current value
$5.38 Million
Previous $1.85 Million 165.46%
% of portfolio
0.16%
Previous 0.15%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $2.92 Million - $3.53 Million
10,869 Added 168.93%
17,303 $4.92 Million
Q4 2023

Feb 01, 2024

SELL
$255.7 - $288.46 $3.18 Million - $3.59 Million
-12,440 Reduced 65.91%
6,434 $1.85 Million
Q3 2023

Nov 06, 2023

SELL
$218.65 - $271.46 $15,305 - $19,002
-70 Reduced 0.37%
18,874 $5.07 Million
Q2 2023

Aug 01, 2023

SELL
$214.27 - $253.37 $145,275 - $171,784
-678 Reduced 3.46%
18,944 $4.21 Million
Q1 2023

May 05, 2023

BUY
$225.79 - $275.2 $669,015 - $815,417
2,963 Added 17.79%
19,622 $4.74 Million
Q4 2022

Jan 24, 2023

SELL
$229.03 - $291.01 $38,018 - $48,307
-166 Reduced 0.99%
16,659 $0
Q3 2022

Nov 10, 2022

SELL
$224.46 - $253.15 $69,582 - $78,476
-310 Reduced 1.81%
16,825 $3.79 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $325,301 - $362,003
-1,410 Reduced 7.6%
17,135 $4.17 Million
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $518,573 - $573,678
2,365 Added 14.62%
18,545 $4.49 Million
Q4 2021

Feb 02, 2022

BUY
$198.88 - $227.6 $698,665 - $799,558
3,513 Added 27.73%
16,180 $3.64 Million
Q3 2021

Oct 28, 2021

SELL
$212.27 - $248.7 $187,009 - $219,104
-881 Reduced 6.5%
12,667 $2.69 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $10,043 - $11,143
43 Added 0.32%
13,548 $3.3 Million
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $151,120 - $176,106
681 Added 5.31%
13,505 $3.36 Million
Q4 2020

Feb 09, 2021

SELL
$216.38 - $257.67 $201,449 - $239,890
-931 Reduced 6.77%
12,824 $2.95 Million
Q3 2020

Nov 03, 2020

SELL
$234.65 - $260.95 $84,004 - $93,420
-358 Reduced 2.54%
13,755 $3.5 Million
Q2 2020

Jul 31, 2020

BUY
$197.81 - $242.74 $301,264 - $369,693
1,523 Added 12.1%
14,113 $3.33 Million
Q1 2020

May 01, 2020

SELL
$182.24 - $241.7 $106,063 - $140,669
-582 Reduced 4.42%
12,590 $2.55 Million
Q4 2019

Feb 03, 2020

BUY
$189.21 - $243.2 $77,765 - $99,955
411 Added 3.22%
13,172 $3.18 Million
Q3 2019

Nov 01, 2019

SELL
$174.11 - $208.62 $23,853 - $28,580
-137 Reduced 1.06%
12,761 $2.47 Million
Q2 2019

Aug 01, 2019

SELL
$166.7 - $195.41 $333 - $390
-2 Reduced 0.02%
12,898 $2.38 Million
Q1 2019

May 01, 2019

BUY
$180.87 - $203.88 $18,267 - $20,591
101 Added 0.79%
12,900 $2.45 Million
Q4 2018

Jan 31, 2019

BUY
$178.4 - $208.25 $126,485 - $147,649
709 Added 5.86%
12,799 $2.49 Million
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $744,495 - $839,320
-4,018 Reduced 24.94%
12,090 $2.51 Million
Q2 2018

Aug 02, 2018

BUY
$166.05 - $186.51 $39,852 - $44,762
240 Added 1.51%
16,108 $2.97 Million
Q1 2018

May 11, 2018

SELL
$169.43 - $198.0 $117,414 - $137,214
-693 Reduced 4.18%
15,868 $2.71 Million
Q4 2017

Feb 07, 2018

BUY
$168.79 - $188.59 $293,525 - $327,958
1,739 Added 11.73%
16,561 $2.88 Million
Q3 2017

Nov 06, 2017

BUY
$167.29 - $191.0 $2.48 Million - $2.83 Million
14,822
14,822 $2.76 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sigma Planning Corp Portfolio

Follow Sigma Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.